Apellis Pharmaceuticals Share Price Today
(NASDAQ: APLS)
Apellis Pharmaceuticals share price is $29.01 & ₹2,513.43 as on 1 Feb 2025, 2.30 'hrs' IST
$29.01
Market is closed - opens 8 PM, 03 Feb 2025
View live Apellis Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Apellis Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Apellis Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.
Apellis Pharmaceuticals share price movements
- Today's Low: $28.97Today's High: $30.57
0.14%
Downside
Day's Volatility :5.23%
Upside
5.1%
- 52 Weeks Low: $24.3452 Weeks High: $71.90
16.1%
Downside
52 Weeks Volatility :66.15%
Upside
59.65%
Apellis Pharmaceuticals (APLS) Returns
Apellis Pharmaceuticals (APLS) Key Statistics
in dollars & INR
How to invest in Apellis Pharmaceuticals Stock (APLS) from India?
It is very easy for Indian residents to invest directly in Apellis Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Apellis Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Apellis Pharmaceuticals or APLS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Apellis Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Apellis Pharmaceuticals shares which would translate to 0.030 fractional shares of Apellis Pharmaceuticals as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Apellis Pharmaceuticals, in just a few clicks!
Returns in Apellis Pharmaceuticals (APLS) for Indian investors in Rupees
The Apellis Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Apellis Pharmaceuticals investment value today
Current value as on today
₹50,790
Returns
Returns from Apellis Pharmaceuticals Stock
Dollar Returns
₹4,419 (+4.42%)
Indian investors sentiment towards Apellis Pharmaceuticals (APLS)
Global Institutional Holdings in Apellis Pharmaceuticals
Wellington Management Company LLP
12.51%
EcoR1 Capital, LLC
9.56%
venBio Select Advisor LLC
8.93%
Vanguard Group Inc
7.89%
BlackRock Inc
4.98%
Deep Track Capital, LP
3.54%
Analyst Recommendation on Apellis Pharmaceuticals
Buy
82%Buy
17%Hold
0%Sell
Based on 23 Wall street analysts offering stock ratings for Apellis Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Apellis Pharmaceuticals Stock (APLS)
What analysts predicted
Upside of 58.91%
Target:
$46.10
Current:
$29.01
Insights on Apellis Pharmaceuticals Stock (Ticker Symbol: APLS)
Price Movement
In the last 1 year, APLS stock has moved down by -52.0%Decreasing Revenue
Revenue is down for the last 2 quarters, 199.68M → 196.83M (in $), with an average decrease of 1.4% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -37.65M → -57.44M (in $), with an average decrease of 52.6% per quarterAPLS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.3% return, outperforming this stock by 112.3%APLS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 101.4% return, outperforming this stock by 125.9%Price to Sales
ForAPLS every $1 of sales, investors are willing to pay $5.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.
Apellis Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Apellis Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Apellis Pharmaceuticals (APLS) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -8.35% | -10.33% | -51.42% | -24.89% | -29.98% |
 | 4.84% | 54.26% | 30.47% | -32.9% | 299.34% |
 | -4.49% | -36.24% | -27.73% | 9.67% | 100.25% |
 | 8.04% | -8.07% | 3.23% | 72.89% | 90.19% |
 | 18.64% | 4.59% | 60.15% | 90.8% | 141.72% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.67 | -1.07 | -0.16 | NA | 1.94 |
| 160.8 | NA | 0.04 | -3.32 | -0.02 | -0.01 | NA | 79.73 |
| 17.01 | 17.01 | 1.06 | 45.08 | 0.17 | 0.07 | NA | 272.04 |
| 32.84 | NA | 1.16 | 0.49 | -0.03 | 0.12 | NA | 60.65 |
| NA | NA | -0.49 | -0.18 | -15.01 | -0.03 | NA | 0.25 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $3.8B | -29.98% | NA | -34.97% |
| Buy | $29.0B | 299.34% | 160.8 | -15.36% |
| Buy | $75.5B | 100.25% | 17.01 | 33.61% |
| Buy | $113.7B | 90.19% | 32.84 | -4.51% |
| Buy | $35.3B | 141.72% | NA | -15.86% |
Apellis Pharmaceuticals Dividend announcements
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals’s price-to-earnings ratio stands at None
Read More
About Apellis Pharmaceuticals
Management People of Apellis Pharmaceuticals
Important FAQs about investing in APLS Stock from India :
What is Apellis Pharmaceuticals share price today?
Apellis Pharmaceuticals share price today stands at $29.01, Open: $30.30 ; Previous Close: $30.39 ; High: $30.57 ; Low: $28.97 ; 52 Week High: $71.90 ; 52 Week Low: $24.34.
The stock opens at $30.30, after a previous close of $30.39. The stock reached a daily high of $30.57 and a low of $28.97, with a 52-week high of $71.90 and a 52-week low of $24.34.
Can Indians buy Apellis Pharmaceuticals shares?
Yes, Indians can invest in the Apellis Pharmaceuticals (APLS) from India.
With INDmoney, you can buy Apellis Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Apellis Pharmaceuticals at zero transaction cost.
How can I buy Apellis Pharmaceuticals shares from India?
It is very easy to buy Apellis Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Apellis Pharmaceuticals (APLS) be purchased?
Yes, you can buy fractional shares of Apellis Pharmaceuticals with INDmoney app.
What are the documents required to start investing in Apellis Pharmaceuticals stocks?
To start investing in Apellis Pharmaceuticals, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Apellis Pharmaceuticals Stock (APLS)?
Today’s highest price of Apellis Pharmaceuticals (APLS) is $30.57.
Today’s lowest price of Apellis Pharmaceuticals (APLS) is $28.97.
What is today's market capitalisation of Apellis Pharmaceuticals?
What is the 52 Week High and Low Range of Apellis Pharmaceuticals Stock (APLS)?
52 Week High
$71.90
52 Week Low
$24.34
What are the historical returns of Apellis Pharmaceuticals (APLS)?
1 Month Returns
-8.35%
3 Months Returns
-10.33%
1 Year Returns
-51.42%
5 Years Returns
-29.98%
Who is the Chief Executive Officer (CEO) of Apellis Pharmaceuticals ?
Discover More
Sensient Technologies Corp$75.51
-0.05%
Grupo Aeroportuario Del Sureste, Sabdecv$274.47
-3.97%
Fidelity High Dividend Etf$50.50
-0.81%
Apogee Therapeutics$41.26
-2.92%
Ttm Technologies Inc$24.58
+0.0%
Dimensional International Co$30.41
-0.98%
Brunswick Corporation$67.44
-2.32%
Springworks Therapeutics Inc$37.50
+0.73%
Corcept Therapeutics Inc$67.00
-4.15%